Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 1:51 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 361–384 of 399 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Testosterone Clear all

Conditions: Advanced Cancer
Interventions: Testosterone, Placebo; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 2
States / cities: Houston, Texas

Conditions: HIV Infections
Interventions: Testosterone; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 70 Years · Male only
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2006
U.S. locations: 26
States / cities: Los Angeles, California • Palo Alto, California • San Diego, California + 16 more

Conditions: Prostate Cancer
Interventions: [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Male only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Hypogonadism, Opioid-Related Disorders, Male Infertility
Interventions: Clomiphene citrate, Placebo; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: HIV Associate Weight Loss
Interventions: Testosterone enanthate, Placebo; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Male Hypogonadism
Interventions: Oral testosterone undecanoate, topical testosterone gel; Drug
Lead sponsor: Clarus Therapeutics, Inc.; Industry
Eligibility: 18 Years to 75 Years · Male only
Enrollment: 325 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 25
States / cities: Birmingham, Alabama • Calera, Alabama • Huntsville, Alabama + 20 more

Conditions: Peyronie's Disease (PD)
Interventions: Xiaflex®, Aveed; Drug
Lead sponsor: Men's Health Boston; Other
Eligibility: 18 Years to 70 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Chestnut Hill, Massachusetts

Conditions: Healthy Men, Male Contraception, Healthy Women, Product Transference
Interventions: Nestorone + Testosterone Combination Gel; Drug
Lead sponsor: Kimberly Myer; Other
Eligibility: 18 Years to 50 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 2
States / cities: Torrance, California • Seattle, Washington

Conditions: Prostatic Neoplasms
Interventions: Zolpidem, ECG; Drug · Diagnostic Test
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Breast Cancer, Vaginal Dryness, Dyspareunia, Sexual Health Quality of Life
Interventions: Testosterone; Drug
Lead sponsor: Creighton University; Other
Eligibility: 50 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Panhypopituitarism
Interventions: Transdermal Testosterone gel; Drug
Lead sponsor: Charles Drew University of Medicine and Science; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2010
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Hypogonadism
Interventions: Oral Testosterone Undecanoate, Axiron Testosterone Topical Solution; Drug
Lead sponsor: Clarus Therapeutics, Inc.; Industry
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Northbrook, Illinois

Conditions: Contraception
Interventions: Acyline, Testosterone Gel, Depo-Medroxyprogesterone; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Female Hormone Profile
Interventions: Vitamin D (Cholecalciferol ), Placebo Group; Dietary Supplement
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Hypogonadism
Interventions: Oral Testosterone Undecanoate; Drug
Lead sponsor: Clarus Therapeutics, Inc.; Industry
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Torrance, California

Conditions: Endocrine Dysfunction, Trauma, Brain Injury
Interventions: Androgel (Testosterone Gel), Placebo gel; Drug · Other
Lead sponsor: Craig Hospital; Other
Eligibility: 16 Years to 65 Years · Male only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Englewood, Colorado

Conditions: ERYTHROCYTOSIS
Interventions: Finasteride; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Prostate Cancer, Castration-Resistant Prostate Cancer
Interventions: Transdermal Testosterone, Standard of Care, Enzalutamide; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Secondary Hypogonadism
Interventions: Placebo, topical testosterone, Androxal; Drug
Lead sponsor: Repros Therapeutics Inc.; Industry
Eligibility: 21 Years to 65 Years · Male only
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 18
States / cities: Garden Grove, California • Sacramento, California • San Diego, California + 11 more

Conditions: Rotator Cuff Tears
Interventions: Testosterone cypionate, Placebos; Drug
Lead sponsor: Orthopedic Institute, Sioux Falls, SD; Other
Eligibility: 45 Years to 75 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Brain and Central Nervous System Tumors, Musculoskeletal Complications
Interventions: testosterone gel applied to skin, whey powder protein; Drug · Dietary Supplement
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years to 120 Years · Male only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hypoactive Sexual Desire Disorder
Interventions: Testosterone Transdermal System, Placebo patch; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 45 Years to 70 Years · Female only
Enrollment: 1,271 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 115
States / cities: Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 97 more

Conditions: Healthy
Interventions: Oral Testosterone, Acyline; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Low Testosterone, Hypogonadism, Pain
Interventions: Testosterone Gel, Placebo Gel; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients

Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat

[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer

Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration

Testosterone and Physical Function in HIV+ Men

Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men

Xiaflex® Plus Testosterone Treatment Pilot Study Protocol

Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males

The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females

Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy

Testosterone Gel Applied to Women With Pituitary Gland Problems

A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men

Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum

Acute Vitamin D Supplementation on Testosterone in Females

Phlebotomy Study of Testosterone Undecanoate

Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy

H-36731: Finasteride in Management of Elevated Red Blood Cells

Testosterone Therapy in Castration Resistant Prostate Cancer

Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism

Can Testosterone Accelerate Injury Recovery After Arthroscopic Rotator Cuff Repair

Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma

Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women

ORAL T-8 Oral Testosterone for Male Hormonal Contraception

Testosterone and Pain Sensitivity